Robert G. L. Shorr
Fondateur chez Cornerstone Pharmaceuticals, Inc.
Postes actifs de Robert G. L. Shorr
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Directeur/Membre du Conseil | - | - |
| Directeur Technique/Scientifique/R&D | - | - | |
| Fondateur | - | - | |
| Directeur Général | 01/01/2000 | 10/10/2014 | |
| Stony Brook University | Corporate Officer/Principal | 01/01/1998 | - |
| Tissue Engineering Charities, Inc. | Directeur/Membre du Conseil | 16/05/2011 | - |
| Imperial College London | Directeur/Membre du Conseil | 01/01/1999 | - |
Historique de carrière de Robert G. L. Shorr
Anciens postes connus de Robert G. L. Shorr
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Membre du Conseil | 31/03/2005 | 01/02/2018 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur/Membre du Conseil | - | 28/04/2005 |
| UNITED THERAPEUTICS CORPORATION | Directeur Technique/Scientifique/R&D | 01/01/2005 | 01/01/2005 |
| Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 01/01/1988 | 01/01/1988 |
| AT Biochem, Inc. | Directeur Technique/Scientifique/R&D | - | - |
| Fondateur | 07/05/2010 | - | |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formation de Robert G. L. Shorr
| University of London | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
| Royaume-Uni | 4 |
Opérationnelle
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Entreprise privées | 5 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
| AT Biochem, Inc. | |
| Tissue Engineering Charities, Inc. | |
| Smithkline & French Laboratories US, Inc. |
- Bourse
- Insiders
- Robert G. L. Shorr
- Expérience
